Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB GLENMARK PHARMA UNICHEM LAB/
GLENMARK PHARMA
 
P/E (TTM) x 236.1 -31.4 - View Chart
P/BV x 1.4 2.9 49.7% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 UNICHEM LAB   GLENMARK PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-23
GLENMARK PHARMA
Mar-23
UNICHEM LAB/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs467487 95.9%   
Low Rs226349 64.8%   
Sales per share (Unadj.) Rs190.7460.4 41.4%  
Earnings per share (Unadj.) Rs-28.713.4 -214.7%  
Cash flow per share (Unadj.) Rs-12.635.0 -36.0%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs344.2335.1 102.7%  
Shares outstanding (eoy) m70.41282.17 25.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.80.9 200.0%   
Avg P/E ratio x-12.131.3 -38.6%  
P/CF ratio (eoy) x-27.511.9 -230.3%  
Price / Book Value ratio x1.01.2 80.7%  
Dividend payout %018.7 -0.0%   
Avg Mkt Cap Rs m24,396117,953 20.7%   
No. of employees `000NANA-   
Total wages/salary Rs m3,56427,810 12.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m13,430129,901 10.3%  
Other income Rs m3853,168 12.2%   
Total revenues Rs m13,815133,069 10.4%   
Gross profit Rs m-84115,125 -5.6%  
Depreciation Rs m1,1346,113 18.6%   
Interest Rs m1733,496 5.0%   
Profit before tax Rs m-1,7648,685 -20.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2594,911 5.3%   
Profit after tax Rs m-2,0223,774 -53.6%  
Gross profit margin %-6.311.6 -53.8%  
Effective tax rate %-14.756.5 -25.9%   
Net profit margin %-15.12.9 -518.3%  
BALANCE SHEET DATA
Current assets Rs m15,88598,737 16.1%   
Current liabilities Rs m6,39650,455 12.7%   
Net working cap to sales %70.737.2 190.1%  
Current ratio x2.52.0 126.9%  
Inventory Days Days517 764.7%  
Debtors Days Days1,600115 1,389.1%  
Net fixed assets Rs m15,91176,920 20.7%   
Share capital Rs m141282 49.9%   
"Free" reserves Rs m24,09294,281 25.6%   
Net worth Rs m24,23394,563 25.6%   
Long term debt Rs m63638,521 1.7%   
Total assets Rs m31,829175,658 18.1%  
Interest coverage x-9.23.5 -263.7%   
Debt to equity ratio x00.4 6.4%  
Sales to assets ratio x0.40.7 57.1%   
Return on assets %-5.84.1 -140.4%  
Return on equity %-8.34.0 -209.1%  
Return on capital %-6.49.2 -69.9%  
Exports to sales %69.70-   
Imports to sales %12.40-   
Exports (fob) Rs m9,366NA-   
Imports (cif) Rs m1,669NA-   
Fx inflow Rs m9,36646,464 20.2%   
Fx outflow Rs m1,66912,712 13.1%   
Net fx Rs m7,69733,751 22.8%   
CASH FLOW
From Operations Rs m-8516,254 -13.6%  
From Investments Rs m2,028-5,285 -38.4%  
From Financial Activity Rs m-813-775 105.0%  
Net Cashflow Rs m746325 229.4%  

Share Holding

Indian Promoters % 70.2 46.7 150.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.3 34.7 32.6%  
FIIs % 0.8 23.7 3.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.8 53.4 55.8%  
Shareholders   20,877 209,931 9.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Unichem Lab vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Unichem Lab vs Glenmark Pharma Share Price Performance

Period Unichem Lab Glenmark Pharma S&P BSE HEALTHCARE
1-Day 1.90% -0.57% 1.18%
1-Month -5.40% 5.16% -0.75%
1-Year 78.12% 112.94% 61.82%
3-Year CAGR 16.06% 27.51% 18.16%
5-Year CAGR 19.87% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Unichem Lab share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Unichem Lab hold a 70.2% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Unichem Lab and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Unichem Lab paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Unichem Lab, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.